JAPAN TOBACCO (2914) FY2026 Q1 Earnings Report

Quick View

Executive Summary

For Q1 of the fiscal year ending December 2026, Japan Tobacco achieved an increase in operating income exceeding its revenue growth rate, driven by price revisions and resilient volumes in its core tobacco business. Revenue was ¥9,239.6B (+15.2% YoY), operating income was ¥3,045.5B (+24.7%), profit before tax was ¥2,876.6B (+29.9%), and quarterly profit attributable to owners of the parent was ¥1,970.4B (+25.1%). The operating margin improved from 30.5% in the same period of the previous year to 33.0%, indicating that the earnings results included qualitative margin improvement in addition to the benefit of higher revenue.

Factors Affecting Earnings

【Revenue】Revenue was ¥9,239.6B, up +15.2% YoY. The core tobacco business expanded to external revenue of ¥8,855.5B (+15.8%), becoming the main driver of company-wide growth. Revenue from tobacco products manufactured by the Company was ¥8,485.2B (+16.2%), primarily reflecting pricing effects in Japan, Russia, Turkey, the United States, and other markets. The processed food business generated ¥378.3B (+3.7%), recording modest revenue growth due to price revisions.

【Profit and Loss】Operating income was ¥3,045.5B (+24.7%), and the operating margin was 33.0% (30.5% in the previous year), an improvement of 249bp. Adjusted operating income in the tobacco business of ¥3,254.1B (+21.4%; adjusted operating margin of 36.7%) led the increase. Financial expenses declined to ¥342.4B (¥401.8B in the previous year), pushing up profit before tax, while income taxes increased to ¥904.2B (¥665.2B in the previous year), resulting in an effective tax rate of 31.4%. The decline in amortization of intangible assets associated with acquisitions to ¥120.9B (¥174.9B in the previous year) also contributed to the increase in operating income. Both revenue and profit increased.

Segment Analysis

The core business is the tobacco business, which accounts for 95.8% of the revenue mix. External revenue in this business was ¥8,855.5B (+15.8%), operating income was ¥3,254.1B (+21.4%), and the margin remained high at 36.7%, effectively driving company-wide profit growth. By cluster, adjusted operating income increased across all regions: Asia at ¥886.9B (+30.7%), Western Europe at ¥963.4B (+18.9%), and EMA at ¥1,403.8B (+17.9%). The processed food business recorded revenue of ¥378.3B (+3.7%) and operating income of ¥17.4B (+119.0%), improving its margin to 4.6%; however, it has at times reported losses due to the impact of restructuring expenses, and the gap in profitability compared with the tobacco business remains substantial.

Key Financial Indicators

Profitability: ROE 4.8%, operating margin 33.0% (30.5% in the previous year)
Cash quality: Operating CF/Net Income 0.20x (Operating CF of ¥396.0B versus net income of ¥1,970.4B), FCF of ¥271.0B
Investment efficiency: Capital expenditures of ¥240.4B / depreciation and amortization of ¥444.5B, or 0.54x
Financial soundness: Equity Ratio 48.9%, current ratio 188.2% (current assets of ¥3,587.4B ÷ current liabilities of ¥1,906.7B)

Cash Flow Analysis

Operating CF was ¥396.0B, only 0.20x net income of ¥1,970.4B. The main factors weighing on cash flow were an increase in trade receivables of ¥681.9B, a decrease in trade payables of ¥439.6B, and a decrease in tobacco taxes payable and other items of ¥1,014.3B. Investing CF was △¥124.9B, primarily due to capital expenditures of ¥240.4B. Financing CF was △¥1,598.2B, mainly reflecting dividend payments of ¥2,258.8B. FCF was ¥271.0B and did not cover dividend payments. Cash generation requires monitoring, with the resolution of working capital movements becoming a key focus going forward.

Quality of Earnings

Net income was ¥1,972.4B against profit before tax of ¥2,876.6B, after deducting income taxes of ¥904.2B (effective tax rate of 31.4%); there was no significant divergence attributable to temporary factors. Non-operating income and expenses comprised financial income of ¥173.5B and financial expenses of ¥342.4B, resulting in a net burden of ¥168.9B. Operating CF was significantly below net income (0.20x), and the divergence between accrual-based earnings and cash resulting from increased working capital is the key point to monitor regarding earnings quality this period.

Earnings Forecast and Guidance

Against the full-year forecast (revenue ¥3,697.0B → correction of misstatement: ¥36,970B, operating income ¥9,210B, profit attributable to owners of the parent ¥5,700B), Q1 progress rates were 25.0% for revenue, 33.1% for operating income, and 34.6% for net income, all exceeding the standard progress rate of 25%. There were no revisions to the earnings forecast or dividend forecast. Operating income and net income are progressing ahead of schedule, suggesting that the pricing effects materialized earlier than expected.

Shareholder Returns

The full-year dividend forecast is ¥242 per share, representing a Payout Ratio of approximately 75.4% against forecast EPS of ¥321.06. Based on current-period profit of ¥5,710B adjusted for the impact of the litigation settlement, the Company has disclosed a Payout Ratio benchmark of 75.2%. Share repurchases in Q1 were small at ¥8.4B, with dividends forming the core of shareholder returns. Dividend payments of ¥2,258.8B during the quarter exceeded FCF of ¥271.0B, making the recovery of full-year cash generation a focus from the perspective of funding dividends.

Catalysts

【Short Term】Expansion of the market share of RRP (the Ploom series) in each market, as well as the continued realization of pricing effects in major markets.

【Long Term】The trend in the financial burden of Annual contribution payments associated with the Canadian litigation settlement, and progress toward achieving the medium- to long-term average annual growth target for adjusted operating income on a constant-currency basis (mid to high single digit).

Industry Benchmark (Reference; Prepared by the Company)

Industry Benchmark (food_beverage)

Profitability and Returns

The Company’s operating margin and net profit margin are positioned at relatively high levels within the industry.

Growth and Capital Efficiency

A double-digit revenue growth rate represents relatively strong growth even within the food and beverage industry.

※Source: Prepared by the Company

Risk Factors

1. Regulatory and litigation risk: Tobacco tax increases, tighter advertising and packaging regulations, and ongoing Annual contribution payments associated with the settlement of smoking-related litigation in Canada may create a continuing financial burden.

2. Foreign exchange and geopolitical risk: As the business spans broad regions, including EMA (Russia, Turkey, the United States, and others) and Asia, it is susceptible to the effects of foreign exchange translation differences (OCI of ¥29.3B recorded in the current period) and geopolitical conditions.

3. Working capital and cash conversion risk: Operating CF/Net Income remains at 0.20x, with increases in trade receivables and inventories coinciding with decreases in trade payables and tobacco taxes payable and other items. The delay in cash conversion relative to profit growth is subject to monitoring.

Key Earnings Highlights

1. Pricing effects in the core tobacco business materialized across all regions (Asia, Western Europe, and EMA), and the improvement in the adjusted operating margin YoY is observable as a qualitative change in the earnings structure.

2. While the full-year progress rates for both operating income and net income exceed the standard progress rate, the fact that operating CF remains at 0.20x net income is clear in the earnings data as a timing difference between accounting profit growth and cash generation.

3. Goodwill amounts to ¥29,545.4B, accounting for 71.8% of net assets, resulting in a financial structure under IFRS in which impairment would have a relatively significant impact on capital and profit.

Theoretical Share Price (Reference Value)

Sensitivity: ¥2,609–¥2,755 at ±1% for the cost of equity, and ¥2,672–¥2,693 at ±0.1 for ω.

Notes:

• Goodwill represents a high proportion of net assets, and the assumptions would change substantially if impairment were recognized.
• Net assets as of the end of the quarter are used (there is a timing mismatch with the full-year forecast).

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated values based solely on publicly disclosed data; these are not forecasts of the market share price or recommendations of any specific investment action, and do not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI through an integrated analysis of XBRL earnings summary data and PDF earnings presentation materials. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting with a professional where necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q1 was a strong earnings quarter, with revenue, operating income and profit attributable to owners all growing at double-digit rates, although cash conversion remained weak. Revenue increased 15.2% YoY to ¥923.96bn. Operating income rose 24.7% YoY to ¥304.55bn, outpacing revenue by 9.5 percentage points. Profit attributable to owners increased 25.1% YoY to ¥197.04bn, while basic EPS rose to ¥110.99 from ¥88.69. Gross profit increased 17.9% YoY to ¥544.96bn. The gross margin expanded by 140bp to 59.0%, from 57.7% in FY2025 Q1. The operating margin expanded by 250bp to 33.0%, from 30.5%, demonstrating favorable operating leverage despite SG&A rising 10.1% YoY to ¥246.98bn. The net margin improved by 160bp to 21.3%, from 19.7%. The tobacco business was the principal earnings engine, generating ¥885.55bn of external revenue and ¥325.41bn of adjusted operating income. Tobacco adjusted operating income increased 21.4% YoY, and its adjusted margin improved 170bp to 36.7%. Processed food revenue grew 3.7% YoY to ¥37.83bn and adjusted operating income more than doubled to ¥1.74bn, but its 4.6% adjusted margin remains modest relative to tobacco. Management’s Q1 performance is ahead of the implied straight-line pace for the full-year forecasts, with 25.0% revenue progress, 33.1% operating-income progress and 34.6% net-income progress. However, operating cash flow was only ¥39.60bn, equivalent to 0.20x net income, due primarily to working-capital outflows. Receivables rose by ¥68.19bn, inventories increased by ¥11.73bn and payables declined by ¥43.96bn in the quarter, constraining conversion of reported profit into cash. The balance sheet remains adequately capitalized with a 48.9% equity ratio, but goodwill accounts for 71.8% of equity and materially raises the importance of preserving acquired-business cash flows. The full-year dividend framework implies a 75.2% payout ratio based on adjusted profit of ¥571.0bn, making sustained operating cash generation and tobacco pricing power central to capital-return capacity. The outlook therefore combines favorable earnings momentum and margin resilience with heightened attention to working-capital normalization, foreign-exchange effects, regulatory developments, litigation-related cash obligations and goodwill impairment risk.

Profitability Analysis

Annualized DuPont ROE is 19.1%, comprising a 21.3% net profit margin, 0.443x annualized asset turnover and 2.03x financial leverage. The high ROE is driven principally by exceptional margin generation rather than rapid asset utilization; annualized turnover is moderate given the asset base includes ¥2,954.54bn of goodwill. Margin expansion was the largest favorable DuPont contributor in the quarter: EBIT margin rose 250bp YoY to 33.0% and net margin rose 160bp to 21.3%. Revenue growth of 15.2% exceeded SG&A growth of 10.1%, producing positive operating leverage. Gross-margin expansion of 140bp indicates that pricing, mix and/or input-cost management more than offset cost-of-sales growth of 11.6%. The tobacco segment is the core business, contributing 99.1% of segment adjusted operating income before corporate and other costs, with a 36.7% adjusted operating margin. By cluster, tobacco adjusted operating income grew 30.7% in Asia to ¥88.69bn, 18.9% in Western Europe to ¥96.34bn and 17.9% in EMA to ¥140.38bn; EMA remains the largest profit contributor. Processed food adjusted operating profit improved from ¥0.79bn to ¥1.74bn, and margin rose 240bp to 4.6%, though the absolute contribution is limited. The tax burden was 0.685, below the 0.70 reference level, reflecting a 31.4% effective tax rate and moderating conversion of pre-tax profit into net income. The interest burden remained healthy at 0.945 despite net finance costs of ¥16.89bn, with finance costs declining 14.8% YoY to ¥34.24bn. Annualized ROA, calculated using Q1 profit annualized against average total assets, is approximately 9.4%, strong but below the 10% reference threshold. Reported operating income includes ¥12.09bn of amortization of acquisition-related intangibles and ¥2.88bn of adjustment expenses, principally ¥2.83bn of restructuring costs. Adjusted operating income rose 22.8% YoY to ¥315.52bn, supporting the view that the improvement is not solely explained by exceptional items. As a tobacco group, the durability of these margins ultimately depends on price realization, mix, excise-tax dynamics and ongoing consumer demand in a structurally regulated category.

Growth Assessment

Revenue growth was led by tobacco, where external revenue increased 15.8% YoY to ¥885.55bn and own-manufactured tobacco-product revenue increased 16.2% to ¥848.52bn. Cluster growth was broad-based: own-product revenue grew 13.4% in Asia, 15.9% in Western Europe and 18.0% in EMA. EMA generated the largest own-product revenue increase in absolute terms, adding ¥63.34bn YoY, while Asia delivered the fastest adjusted-profit growth. Processed food external revenue grew 3.7% YoY to ¥37.83bn, providing diversification but not a material group-level growth driver. The Q1 operating-income progress rate of 33.1% is 8.1 percentage points above the standard 25% first-quarter pace, while net-income progress of 34.6% is 9.6 percentage points above the same benchmark. Revenue progress of exactly 25.0% is in line with a straight-line annual cadence. The stronger profit progress versus sales reflects the sharp Q1 margin improvement and lower finance costs. Full-year guidance calls for revenue of ¥3,697.0bn, operating income of ¥921.0bn and profit attributable to owners of ¥570.0bn, implying YoY growth of 6.2% in operating income and 11.7% in net income. The gap between Q1 reported operating-income growth of 24.7% and the 6.2% full-year operating-income growth outlook suggests management expects a more moderate growth rate through the remaining quarters. Earnings quality is supported by a ¥315.52bn adjusted operating-profit result, versus ¥304.55bn reported operating income, because the adjustment bridge is transparent and relatively small relative to revenue. Conversely, the quarterly cash conversion profile does not yet validate reported profit growth. The stated long-term objective of mid- to high-single-digit annual growth in constant-currency adjusted operating income highlights the importance of separating underlying tobacco execution from favorable or adverse translation effects. The discontinued pharmaceutical operation contributed ¥3.29bn of Q1 profit in the prior-year comparison but no profit in FY2026 Q1; therefore, the current 25.1% growth in profit attributable to owners reflects continuing operations more clearly than the headline comparison alone.

Financial Health

Financial health is adequate, supported by ¥3,587.37bn of current assets, ¥4,114.89bn of total equity and a 48.9% equity ratio. The calculated current ratio is 1.88x, based on current assets of ¥3,587.37bn and current liabilities of ¥1,906.66bn, comfortably above 1.0x and indicating no near-term liquidity warning. Calculated working capital is approximately ¥1,680.71bn. Cash and cash equivalents were ¥694.62bn at quarter-end. Debt-to-equity was 1.03x, below the 2.0x aggressive-financing warning threshold, although it denotes meaningful use of debt capital. Current bonds and borrowings rose to ¥224.18bn from ¥79.63bn at FY2025 year-end, while non-current bonds and borrowings declined to ¥1,553.45bn from ¥1,599.06bn. The ¥144.55bn increase in short-term borrowings and commercial paper was partly used alongside cash resources to meet shareholder distributions and the ¥67.53bn redemption of bonds. Current assets substantially exceed short-term debt and current liabilities, limiting immediate maturity-mismatch risk. Finance costs of ¥34.24bn were covered 8.9x by Q1 EBIT, and this annualized interest-coverage indication is strong, though it should be interpreted cautiously because it extrapolates one quarter. Goodwill is the major balance-sheet risk, at ¥2,954.54bn, 35.4% of total assets and 71.8% of equity. This exceeds the 50% goodwill-to-equity warning level and means a material impairment would directly pressure equity and reported earnings. The risk is relevant even under IFRS, where goodwill is not amortized and is instead subject to impairment testing. Net defined-benefit liabilities of ¥246.97bn and non-current provisions of ¥57.17bn add longer-dated obligations, while the disclosed Canada litigation settlement annual contribution remains an ongoing cash and earnings consideration. Currency translation increased other equity during the quarter, with foreign-operation translation differences contributing ¥292.59bn to OCI; this supports reported equity but also evidences substantial foreign-currency exposure.

Notable B/S Changes

Cash and cash equivalents: -¥136.51bn QoQ to ¥694.62bn - reflects dividends, bond redemption and weak Q1 operating cash conversion. Accounts receivable: +¥66.15bn QoQ to ¥706.83bn (+10.3%) - consistent with the ¥68.19bn operating-cash-flow outflow and elevated reported DSO. Goodwill: +¥31.44bn QoQ to ¥2,954.54bn - currency translation and/or acquisition-value movements increase the already high 71.8% goodwill-to-equity exposure; impairment assumptions remain important. Current bonds and borrowings: +¥144.55bn QoQ to ¥224.18bn (+181.5%) - short-term funding increased while long-term bonds and borrowings declined, requiring monitoring of refinancing and liquidity management. Other current liabilities: -¥145.55bn QoQ to ¥858.78bn (-14.5%) - principally consistent with settlement of operating and tax-related liabilities, contributing to weak cash conversion. Retained earnings: -¥34.68bn QoQ to ¥3,178.88bn (-1.1%) - Q1 earnings of ¥197.04bn were more than offset by ¥230.80bn of dividends recognized in equity.

Cash Flow Quality

Cash-flow quality is the principal financial concern in FY2026 Q1. Operating cash flow was ¥39.60bn against net income of ¥197.24bn, resulting in an OCF/net-income ratio of 0.20x, well below the 0.8x quality threshold. This divergence reflects working-capital cash outflows rather than a lack of accounting profitability. Receivables increased by ¥68.19bn, inventories increased by ¥11.73bn and payables decreased by ¥43.96bn, together absorbing ¥123.88bn of cash. Other working-capital movements absorbed a further ¥42.09bn. Tobacco-tax timing was also material: pre-tax tobacco-tax movements contributed ¥27.26bn, but unpaid tobacco taxes decreased by ¥101.43bn, creating a substantial net cash drag. Income taxes paid were ¥61.40bn, up from ¥47.98bn in the prior-year quarter. The reported accruals ratio of 1.9% is low and does not independently indicate elevated accrual-accounting risk; the weak OCF/net-income ratio is instead concentrated in identifiable balance-sheet and tax-payment movements. Quality alerts show DSO of 70 days, inventory days of 262 days and a 170-day cash conversion cycle. DSO above 60 days increases collection and customer-credit sensitivity, particularly in international distribution channels. Inventory days of 262 are well above the 90-day warning level and above processed-food reference levels, although the group’s tobacco inventory, excise-tax and international supply-chain characteristics mean the measure should be monitored in the context of product mix and regulation rather than treated as direct evidence of obsolescence. The 170-day cash conversion cycle exceeds the 120-day warning threshold and is consistent with Q1 cash being tied up in receivables and inventories while payables contracted. Investing cash flow was limited to an outflow of ¥12.49bn; capital expenditures were ¥24.04bn and intangible-asset purchases were ¥3.07bn. Reported free cash flow was ¥27.10bn, positive but small relative to quarterly dividends paid of ¥225.88bn. Financing cash flow was negative ¥159.82bn, mainly reflecting dividends, partly offset by a ¥141.91bn increase in short-term borrowing and commercial paper. Cash and equivalents declined by ¥136.51bn during the quarter to ¥694.62bn. The next periods should demonstrate whether receivable, inventory and tobacco-tax movements reverse and restore cash conversion toward earnings.

Dividend Sustainability

The FY2026 full-year dividend forecast is ¥242 per share, with no revision disclosed. Based on forecast EPS of ¥321.06, the implied dividend payout ratio is 75.4%, broadly consistent with management’s stated 75.2% policy calculation based on adjusted FY2026 profit of ¥571.0bn. This is a high but policy-supported dividend payout for a mature, cash-generative tobacco business. The corresponding forecast cash dividend is approximately ¥429.6bn using the Q1 weighted-average share base of 1.775bn shares, compared with forecast profit attributable to owners of ¥570.0bn. Share repurchases were immaterial in Q1 at ¥0.84bn; therefore, the difference between the dividend payout ratio and total return ratio is negligible for the quarter. Quarterly dividends paid of ¥225.88bn exceeded both Q1 net income of ¥197.24bn and reported free cash flow of ¥27.10bn. This does not by itself establish unsustainability because dividend payment timing is seasonal and the group holds substantial liquidity, but it reinforces that recurring cash conversion must improve over the remainder of the year. Cash and equivalents of ¥694.62bn and the 1.88x current ratio provide near-term distribution capacity. The full-year dividend framework explicitly incorporates the effects of Canadian litigation-settlement payments through an adjustment to profit, which improves transparency around that cash obligation. Dividend sustainability is therefore anchored in forecast earnings, pricing power and balance-sheet liquidity, but it is sensitive to persistent working-capital absorption, debt refinancing requirements, adverse currency movements and any impairment of acquisition-related assets.

Risk Assessment

Business risks include Tobacco regulation, excise-tax increases, advertising restrictions and reduced-risk-product regulation remain high-impact risks because tobacco accounts for ¥885.55bn of quarterly external revenue and virtually all segment profit., Litigation and settlement risk remains material, as the adjusted-profit definition excludes the Canada annual contribution associated with the smoking-and-health litigation settlement., Foreign-exchange and geopolitical exposure is significant given broad international operations across Asia, Western Europe and EMA; ¥292.59bn of translation OCI in Q1 demonstrates the scale of currency sensitivity., Volume pressure, illicit trade, consumer downtrading and changing consumer preferences could offset pricing-led revenue growth in mature tobacco markets., Processed-food profitability remains comparatively low, with a 4.6% adjusted operating margin, leaving this business more exposed to food-input, packaging, energy and logistics-cost inflation., High inventory days of 262 and a 170-day cash conversion cycle increase exposure to supply-chain disruption, inventory management execution and working-capital volatility..

Financial risks include Earnings-quality alert: operating cash flow of ¥39.60bn was only 0.20x net income of ¥197.24bn. The immediate cause was receivable growth, inventory growth, lower payables and tobacco-tax-related cash movements; if these do not reverse, reported profitability will not translate into distributable cash at the expected rate., Goodwill-risk alert: goodwill of ¥2,954.54bn equals 71.8% of equity, above the 50% warning threshold. This reflects a balance sheet heavily reliant on the continuing value of acquired tobacco businesses; impairment would reduce equity and earnings materially., High-receivable-days alert: DSO of 70 days exceeds the 60-day threshold. This raises customer-credit and collection risk and was reflected in the ¥68.19bn receivable outflow in Q1., High-inventory-days alert: DIO of 262 days exceeds both the 90-day general warning and the 60-day processed-food benchmark. Tobacco-specific inventory economics may partly explain the level, but the magnitude elevates funding and inventory-valuation risk., Long-cash-conversion-cycle alert: the 170-day cash conversion cycle exceeds the 120-day threshold, indicating that liquidity depends more heavily on funding and cash balances while working capital remains elevated., Debt-to-equity of 1.03x is manageable and below the 2.0x warning level, but short-term bonds and borrowings increased by ¥144.55bn during the quarter, requiring continued refinancing discipline..

Key concerns include Highest priority: normalization of operating cash conversion and working capital, given the substantial divergence between cash flow and earnings., Highest priority: preservation of acquired-business profitability and cash flows to support the ¥2,954.54bn goodwill balance., High priority: tobacco regulatory, tax and litigation outcomes, particularly because these can affect both pricing and cash obligations., High priority: foreign-exchange volatility, which can affect reported earnings, equity and the comparability of international segment performance., Moderate priority: whether Q1 profit growth can remain ahead of the full-year growth plan once favorable first-quarter margin dynamics normalize..

Investment Implications

Key takeaways include Q1 operating performance was strong: revenue grew 15.2%, operating income 24.7% and profit attributable to owners 25.1%, supported by a 250bp operating-margin expansion to 33.0%., Tobacco is the core business, with ¥325.41bn of adjusted operating income and a 36.7% adjusted margin; growth was broad-based across Asia, Western Europe and EMA., Q1 results are ahead of straight-line full-year profit pacing, with 33.1% operating-income and 34.6% net-income progress versus the FY2026 forecasts., The central counterweight is weak cash conversion: OCF/net income was 0.20x and the 170-day cash conversion cycle is elevated., Capital-return capacity is supported by liquidity and forecast earnings, but the 75%-plus dividend payout framework leaves less room for a prolonged cash-flow shortfall., The balance sheet is adequately liquid, but the 71.8% goodwill-to-equity ratio creates material impairment sensitivity..

Metrics to watch include Tobacco own-product revenue and adjusted operating-income growth by Asia, Western Europe and EMA cluster, Constant-currency adjusted operating-income growth versus the stated mid- to high-single-digit medium-term target, Operating cash flow relative to net income, particularly reversal of the ¥68.19bn receivable increase and ¥43.96bn payable reduction, DSO, inventory days and cash conversion cycle, Tobacco-tax payable and pre-tax tobacco-tax cash movements, Goodwill impairment testing assumptions and any changes in goodwill relative to equity, Short-term borrowings, bond maturities, finance costs and interest coverage, Execution against the ¥921.0bn operating-income and ¥570.0bn profit-attributable-to-owners forecasts, Dividend coverage by full-year free cash flow and the sustainability of the ¥242 per-share dividend.

Regarding relative positioning, JT exhibits unusually high profitability for a consumer-staples manufacturer, with a 59.0% gross margin, 33.0% operating margin and 19.1% annualized ROE. Its global tobacco platform provides scale, pricing capacity and strong segment margins, while processed foods are a small, lower-margin diversifier. Relative to businesses with limited acquisition history, however, the group carries a more material goodwill concentration and its Q1 cash conversion is currently weaker than the earnings profile would imply.